Background: Lymph node metastasis (LN+) is a prognostic factor in appendiceal cancers, but predictors and outcomes for LN+ in mucinous appendiceal adenocarcinoma (MAC) remain poorly defined.
Methods: Patients were identified from the 2010 to 2016 NCDB who underwent surgical resection as first-line management for Stage I-III mucinous appendiceal cancer. A LN+ risk-score model was developed using multivariable regression on a training data set and internally validated using a testing data set. Three-year overall survival (OS) was analyzed by Cox proportional hazards regression.
Results: Of 1158 patients, LN+ (N = 244, 21.1%) patients were more likely to have higher pT group and grade of disease, lymphovascular invasion (LVI), and positive margins on univariate analyses. Predictive factors associated with LN+ on multivariable analysis included positive surgical margins (odds ratio [OR] 3.00, P <.0001), higher grade (moderately differentiated: OR, 2.16, P < .0001; poorly or undifferentiated: OR, 3.07, P < .0001), and LVI (OR, 7.28, P < .0001). A validated risk-score model using these factors was developed with good performance (AUC 0.749). LN+ patients had a worse 3-year OS compared with LN- patients (17.4% vs 82.6%, hazard ratio 1.96, P = .001).
Conclusions: LN+ is associated with worse survival in patients with MAC. A risk-score model using margin status, LVI, and grade can accurately risk stratify patients for LN+.
Keywords: appendix cancer; lymph node harvest; lymph node metastases; positive lymph nodes; risk-score model; surgical oncology; surgical outcomes.
© 2020 Wiley Periodicals, Inc.
Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer.Ann Surg Oncol. 2012 Jan;19(1):122-5. doi: 10.1245/s10434-011-1903-0. Epub 2011 Jul 12. Ann Surg Oncol. 2012. PMID: 21748246
The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6. J Gastrointest Surg. 2009. PMID: 19418101
The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy.Eur Urol Focus. 2020 Mar 15;6(2):292-297. doi: 10.1016/j.euf.2018.09.019. Epub 2018 Oct 5. Eur Urol Focus. 2020. PMID: 30297221
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.Br J Cancer. 2017 Dec 5;117(12):1874-1882. doi: 10.1038/bjc.2017.349. Epub 2017 Oct 5. Br J Cancer. 2017. PMID: 28982112 Free PMC article. Clinical Trial.
Lymphovascular Invasion Is Associated with Lymph Node Involvement in Small Appendiceal Neuroendocrine Tumors.Ann Surg Oncol. 2019 Nov;26(12):4008-4015. doi: 10.1245/s10434-019-07637-9. Epub 2019 Jul 29. Ann Surg Oncol. 2019. PMID: 31359272
- Marmor S, Portschy PR, Tuttle TM, Virnig BA. The rise in appendiceal cancer incidence: 2000-2009. J Gastrointest Surg. 2015;19:743-750.
- Mo S, Zhou Z, Ying Z, et al. Epidemiology of and prognositic factors for appendiceal carcinomas: a retrospective, population-based study. Int J Col Dis. 2019;34:1915-1924.
- Xie GD, Liu YR, Jiang YZ, Shao ZM. Epidemiology and survival outcomes of mucinous adenocarcinomas: a SEER population-based study. Sci Rep. 2018;8(1):6117.
- Kelly KJ. Management of appendix cancer. Clin Colon Rectal Surg. 2015;28:247-255.
- Fleischmann I, Warschkow R, Beutner U, Marti L, Schmied BM, Steffen T. Improved survival after retrieveal of 12 or more regional lymph nodes in appendiceal cancer. Eur J Surg Oncol. 2017;43:1876-1885.